OR WAIT null SECS
Scientists are leveraging ddPCR technology to get an accurate read on viral titer and vector copy number.
There are key elements that should be covered when dealing with third-party auditors, according to Siegfried Schmitt, vice president, Technical, at Parexel.
The agency will be reorganizing field force and compliance functions.
November 03, 2023
This is the second biologic approved to treat HS, a painful and reoccurring skin disease.
The EC is calling for interested parties for their safety and orphan drug committees.
According to USP, the products will advance quality and reduce risk in the development and manufacture of biologics and vaccines.
November 02, 2023
Re-evaluating the basics of mAb production may be beneficial for the biopharma industry as a whole.
November 01, 2023
USP offers strategies to minimize residual impurities in downstream processing.
The guidance describes the agency’s procedures for performing remote interactive evaluations at drug manufacturing and bioresearch monitoring facilities.
October 30, 2023
PENBRAYA combines components from two meningococcal vaccines, Trumenba and Nimenrix.
October 25, 2023
The agency’s solidarity mechanism allows Member States to support each other when there is a shortage of a critical medicines.
October 24, 2023
The final guidance document was issued to assist bio/pharma companies in the clinical development and licensure of COVID-19 vaccines.